Pharmaceutical Quality Systems & GMP Compliance

What we do: PKCS implements pharmaceutical quality management systems (QMS), prepares manufacturers for Good Manufacturing Practice (GMP) inspections by Iraqi, UAE, and Saudi authorities, and remediates findings from prior inspections. We work to WHO GMP, EU GMP (Annex-driven), PIC/S, and country-specific overlays so that one quality system carries the manufacturer through inspections in multiple regional markets.

What does GMP compliance mean for MENA market access?

Most regulatory authorities in the region — including the Iraqi MOH, MOHAP/EDE, and SFDA — require evidence that the manufacturing site holds a valid GMP certificate from a recognized authority. Many also conduct their own GMP inspections of foreign manufacturing sites before granting marketing authorization. A failed inspection delays product approval by 12 months or more; in serious cases it triggers withdrawal of products already on the market and refusal of new applications from the same site.

The GMP frameworks themselves are largely harmonized — manufacturers already inspected by the EMA, FDA, MHRA, or PIC/S inspectorates rarely have a fundamental compliance problem. The risk is in the country-specific overlay: the documentation language, the way the inspection is conducted, and the specific elements (e.g., bilingual batch records, regional pharmacopoeial references, local stability data) that regional inspectors emphasize.

What does PKCS deliver in a quality engagement?

• QMS design and implementation — Quality manual, SOPs, deviation and CAPA systems, change control, supplier qualification, and document control aligned with EU GMP / PIC/S / WHO GMP, with overlays for regional inspection expectations.
• Mock GMP audits — Pre-inspection audit conducted by PKCS specialists, simulating an SFDA, MOHAP/EDE, or Iraqi MOH inspection to identify and close gaps before the real inspection.
• Audit remediation — Response to FDA Form 483, EMA non-compliance reports, and regional authority findings, with a corrective action plan that satisfies the issuing authority.
• Supplier and contract manufacturer qualification — Audits of third-party manufacturers, packagers, and laboratories to support the supply chain integrity that authorities increasingly scrutinize.
• Annual product review and product quality review (PQR) — Compilation, statistical review, and reporting of product quality data across batches.
• Inspection preparedness training — Training of site staff on inspection conduct, do-and-don’t behaviors, and document handling.

How does PKCS engage with manufacturing sites?

PKCS works on-site for inspections, audits, and training, and remotely for QMS document development and remediation projects. Engagements range from short focused mock-audits (typically 3–5 days on site) to multi-month QMS rebuild projects following a serious inspection finding. PKCS also works with contract manufacturing organizations (CMOs) and contract development and manufacturing organizations (CDMOs) on a recurring basis to maintain inspection-readiness across multiple client products.

Quality systems and pharmacovigilance — one accountable team

Quality and pharmacovigilance sit at the intersection of post-approval product responsibility. PKCS clients using both services benefit from coordinated handling of complaints, deviations that affect product safety, and field actions that touch both the quality and PV systems.

Related services

• Regulatory Affairs — Dossier preparation and submission.
• Pharmacovigilance Services — PV system implementation and QPPV across MENA.
• Clinical Research Support — GCP-aligned clinical trial support in Iraq and MENA.

Frequently asked questions

Do GCC authorities recognize EU or US GMP certification?

Generally yes — most regional authorities accept GMP certification from PIC/S inspectorates, the EMA, and the FDA as a prerequisite, though many also conduct their own inspection of foreign sites before granting marketing authorization. PKCS prepares manufacturers for both the certification reliance check and the in-region inspection.

How long does a typical mock GMP audit take?

A focused mock audit of a single manufacturing site is typically 3–5 days on site, plus a written report and CAPA recommendations. Full QMS rebuild projects after a serious finding can run 3–6 months.

Can PKCS work with contract manufacturers we don't directly own?

Yes. With the marketing authorization holder’s authority, PKCS audits and supports contract manufacturers, packagers, and analytical laboratories as part of supplier qualification and lifecycle management.